• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲红豆杉制剂Isorel的抗肿瘤及免疫调节作用

Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.

作者信息

Jurin M, Zarković N, Hrzenjak M, Ilić Z

机构信息

Department of Experimental Biology and Medicine, Ruder Bosković Institute, Zagreb, Croatia.

出版信息

Oncology. 1993 Nov-Dec;50(6):393-8. doi: 10.1159/000227217.

DOI:10.1159/000227217
PMID:8233280
Abstract

There are numerous data on the immunostimulative and antitumorous activity of various Viscum album tissue extracts. Isorel (Novipharm, Austria) is one of these compounds. We found that in mice an increased number of plaque-forming cells to sheep red blood cells (SRBC) followed the injection of Isorel together with SRBC. Further, survival time of a foreign skin graft was shortened if Isorel was applied at the correct time. Finally, suppressed immune reactivity in tumorous mice recovered following Isorel injection. Isorel was further shown to be cytotoxic to tumor cells in vitro. Its application to tumor-bearing mice could prolong their life but without any therapeutic effect. However, a combination of local irradiation and Isorel was very effective: following 43 Gy of local irradiation to a transplanted methylcholanthrene-induced fibrosarcoma (volume about 240 mm3) growing in syngeneic CBA/HZgr mice, the tumor disappeared in about 25% of the animals; the addition of Isorel increased the incidence of cured animals to over 65%. The combined action of Isorel, influencing tumor viability on the one hand and the host's immune reactivity on the other, seems to be favorable for its antitumor action in vivo.

摘要

关于各种槲寄生组织提取物的免疫刺激和抗肿瘤活性,有大量数据。异瑞(奥地利诺维法姆公司)就是其中一种化合物。我们发现,在小鼠中,将异瑞与绵羊红细胞(SRBC)一起注射后,针对SRBC的噬斑形成细胞数量增加。此外,如果在正确时间应用异瑞,异体皮肤移植的存活时间会缩短。最后,肿瘤小鼠中被抑制的免疫反应性在注射异瑞后恢复。异瑞在体外还被证明对肿瘤细胞具有细胞毒性。将其应用于荷瘤小鼠可延长其寿命,但无任何治疗效果。然而,局部照射与异瑞联合使用非常有效:对同基因CBA/HZgr小鼠体内生长的移植性甲基胆蒽诱导纤维肉瘤(体积约240立方毫米)进行43戈瑞的局部照射后,约25%的动物肿瘤消失;添加异瑞使治愈动物的发生率提高到65%以上。异瑞一方面影响肿瘤活力,另一方面影响宿主免疫反应性,其联合作用似乎有利于其在体内的抗肿瘤作用。

相似文献

1
Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.欧洲红豆杉制剂Isorel的抗肿瘤及免疫调节作用
Oncology. 1993 Nov-Dec;50(6):393-8. doi: 10.1159/000227217.
2
Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice.槲寄生制剂Isorel可改变正常小鼠和荷瘤小鼠的免疫反应。
Anticancer Drugs. 1997 Apr;8 Suppl 1:S27-31. doi: 10.1097/00001813-199704001-00007.
3
An overview on anticancer activities of the Viscum album extract Isorel.欧洲槲寄生提取物Isorel的抗癌活性概述
Cancer Biother Radiopharm. 2001 Feb;16(1):55-62. doi: 10.1089/108497801750096041.
4
[Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].[维索雷尔/异索雷尔——来自欧洲红豆杉的抗癌药物。文件编号20]
Schweiz Rundsch Med Prax. 1990 Mar 13;79(11):332-4.
5
The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship.槲寄生制剂异索雷尔通过影响肿瘤与宿主的关系来抑制黑色素瘤B16F10的生长。
Anticancer Drugs. 1997 Apr;8 Suppl 1:S17-22. doi: 10.1097/00001813-199704001-00005.
6
Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.槲寄生凝集素ML-1与新鲜植物提取物(Isorel)对黑色素瘤B16F10细胞体外生长及致瘤性影响的比较
Cancer Biother Radiopharm. 1998 Apr;13(2):121-31. doi: 10.1089/cbr.1998.13.121.
7
Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.消化道癌症患者围手术期应用欧洲白株树提取物Isorel
Anticancer Res. 2005 Nov-Dec;25(6C):4583-90.
8
The influence of isorel on the advanced colorectal cancer.异瑞乐对晚期结直肠癌的影响。
Cancer Biother Radiopharm. 2003 Feb;18(1):27-34. doi: 10.1089/108497803321269304.
9
Anticarcinogenic and antimetastatic activity of Iscador.伊斯卡多的抗癌和抗转移活性。
Anticancer Drugs. 1997 Apr;8 Suppl 1:S15-6. doi: 10.1097/00001813-199704001-00004.
10
Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.欧洲红豆杉提取物异瑞(Isorel)辅助癌症生物疗法:循证医学研究结果综述
Coll Antropol. 2015 Sep;39(3):701-8.

引用本文的文献

1
The Anti-Inflammatory Activity of ..的抗炎活性
Plants (Basel). 2023 Mar 27;12(7):1460. doi: 10.3390/plants12071460.
2
Systematic analysis of mistletoe prescriptions in clinical studies.系统分析临床研究中的槲寄生处方。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5559-5571. doi: 10.1007/s00432-022-04511-2. Epub 2022 Dec 9.
3
Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with L. Extract: A Case Report.辅助治疗下复发性去分化高级腹膜后脂肪肉瘤患者的长期生存:病例报告。
Integr Cancer Ther. 2021 Jan-Dec;20:1534735421995258. doi: 10.1177/1534735421995258.
4
Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with extracts: A case report.晚期胰腺癌患者接受辅助治疗提取物后的长期生存:一例报告。
World J Gastroenterol. 2019 Mar 28;25(12):1524-1530. doi: 10.3748/wjg.v25.i12.1524.
5
Phenolic compounds from tinctures enhanced antitumor activity in melanoma murine cancer cells.酊剂中的酚类化合物增强了黑色素瘤小鼠癌细胞的抗肿瘤活性。
Saudi Pharm J. 2018 Mar;26(3):311-322. doi: 10.1016/j.jsps.2018.01.011. Epub 2018 Jan 31.
6
(L.) in experimental animal tumors: A meta-analysis.(L.)在实验动物肿瘤中的一项荟萃分析。
Exp Ther Med. 2017 Jun;13(6):2723-2740. doi: 10.3892/etm.2017.4372. Epub 2017 Apr 21.
7
Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.更高剂量的鹿蹄草在动物和人体中的安全性——免疫变化和安全性参数的系统评价。
BMC Complement Altern Med. 2011 Aug 28;11:72. doi: 10.1186/1472-6882-11-72.
8
Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.槲寄生提取物在乳腺癌和妇科癌症中的应用:临床与临床前研究的系统评价
J Exp Clin Cancer Res. 2009 Jun 11;28(1):79. doi: 10.1186/1756-9966-28-79.
9
Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.癌症的非常规疗法:3. 伊斯卡多。加拿大乳腺癌研究倡议替代疗法特别工作组。
CMAJ. 1998 May 5;158(9):1157-9.